Skip to main content
Premium Trial:

Request an Annual Quote

Thermo s Revenues Grow, Earnings Fall in Q4

NEW YORK, Feb. 5 (GenomeWeb News) - ThermoElectron yesterday reported increased revenues but smaller earnings for the fourth quarter of 2003.

 

Thermo's fourth-quarter revenues increased to $583.4 million from $568.7 million a year ago. Its Life and Laboratory Sciences segment, which includes mass spectrometers for proteomics, had $377 million in revenues, up from $333 million in 2002.

 

R&D expenses decreased slightly, to $37 million, from $38.2 million during the same period last year.

 

The company's net income decreased to $61.9 million, or $.37 per share, compared to $87.2 million, or $.51 per share, for the year-ago period. Thermo attributed most of this decrease to discontinued operations and the sale of securities.

 

As of Dec. 31, Thermo had cash and cash equivalents of $303.9 million.

 

The Scan

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.

New Insights Into TP53-Driven Cancer

Researchers examine in Nature how TP53 mutations arise and spark tumor development.

Mapping Single-Cell Genomic, Transcriptomic Landscapes of Colorectal Cancer

In Genome Medicine, researchers present a map of single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer.

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.